Advertisement

Topics

Circassia Pharma Receives 2nd FDA Approval for COPD Treatment in 2 Weeks

20:00 EDT 16 Apr 2019 | BioSpace

COPD is a progressive disease associated with tobacco smoking, air pollution or occupational exposure. It results in difficulties in breathing and increasing episodes of breathlessness.

Original Article: Circassia Pharma Receives 2nd FDA Approval for COPD Treatment in 2 Weeks

NEXT ARTICLE

More From BioPortfolio on "Circassia Pharma Receives 2nd FDA Approval for COPD Treatment in 2 Weeks"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...